EVALUASI PENGGUNAAN ANTIBIOTIK PADA PASIEN PNEUMONIA DI RSUD DR. ADNAAN WD PAYAKUMBUH TAHUN 2019
DOI:
https://doi.org/10.37090/jfl.v10i2.701Abstrak
Abstrac
Pneumonia is an inflammation of the lung parenchyma caused by bacteria, viruses, fungi, and parasites, but pneumonia can also be caused by chemicals or due to physical exposure such as temperature or radiation. The main therapy given to patients with pneumonia caused by bacteria is antibiotics. WHO recommends ATC (Anatomical Therapeutic Chemical) and DDD (Defined Daily Dose) as global standards for the study of drug use, one of which is antibiotics. The purpose of this study was to see an overview of the use of antibiotics using the ATC/DDD and DU 90% methods at Dr. Adnaan WD Payakumbuh Hospital in 2019. This study was a descriptive analytic study with a cross sectional design that was carried out retrospectively using data obtained from patient medical records. . Samples were taken by purposive sampling technique. The results showed that the quantity of antibiotic use from 111 patients in medical records obtained a total of 101.04 grams of DDD/100 days of hospitalization. The most widely used antibiotic was ceftriaxone and the least was cefoperazone. Antibiotics that fall into the 90% segment are Ceftriaxone (36.57%), Levofloxacin (28.39%), Cefotaxime (7.83%), Ciprofloxacin (7.40%), Cefixime (7.11%),Ceftazidime ( 6.24%) DDD/100 patient-days.
Keywords: ATC/DDD, DU90%, evaluation of antibiotic use, pneumonia
Referensi
Alaydrus, S. (2018). Evaluasi Penggunaan Antibiotik Pada Anak Penderita Bronkopneumonia Di Rumah Sakit Provinsi Sulawesi Tengah Periode 2017. Jurnal Mandala Pharmacon Indonesia, 4(02), 83-93.
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., ... & Swanson, J. T. (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clinical infectious diseases, 53(7), e25-e76.
Centers for Disease Control and Prevention. (2015). Antibiotic: antimicrobial Resistance. http://www. cdc. gov/drugresistance/index. html.
Dinas Kesehatan Provinsi Sumatera Barat. (2017) .Jumlah Kasus Wabah/ Endemi pada Manusia. Padang.
Kemenkes, R. I. (2011). Pedoman pelayanan kefarmasian untuk terapi antibiotik. Jakarta: sn.
Gyssens, I. C. (2005). Audits for monitoring the quality of antimicrobial prescriptions. In Antibiotic Policies (pp. 197-226). Springer, Boston, MA.
Hadi, U., Duerink, D.O., Lestari, E.S., Nagelkerke, N.J., Keuter, M., Suwandojo, E., Rahardjo,E.,VandenBroek,P.,danGyssens,I.C.( 2008). Auditof antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clinical Microbiologyand Infectious DiseaseJournal. 14(7): 698–707.
Hartati, S. (2011). Analisis faktor risiko yang berhubungan dengan kejadian pneumonia pada anak balita di RSUD Pasar Rebo Jakarta. Fakultas Ilmu Keperawatan, Program Magister Ilmu Keperawatan, Uiniversitas Indonesia. Depok.
Kementeri kesehatan RI. (2015). Peraturan Menteri Kesehatan Republik Indonesia Nomor 8 Tahun 2015 tentang Program Pengendalian Resistensi Antimikroba di Rumah Sakit.
Kementerian Kesehatan RI. (2013). Riset Kesehatan Dasar 2013. Badan Penelitian Dan Pengembangan Kesehatan.
Kementerian Kesehatan RI. (2011). Peraturan Menteri Kesehatan Republik Indonesia Nomor 2406 Tahun 2011 tentang Pedoman Umum Penggunaan Antibiotika.
Kementerian Kesehatan Republik Indonesia. (2017). Profil Kesehatan Indonesia Tahun 2017.Jakarta.
Lestari, E. S., Severin, J. A., Filius, P. M. G., Kuntaman, K., Duerink, D. O., Hadi, U., ... & Verbrugh, H. A. (2008). Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals. European Journal of Clinical Microbiology & Infectious Diseases, 27(1), 45-51.
Misnadiarly, (2008). Penyakit Infeksi Saluran Napas Pneumoni pada Anak Orang Dewasa, Usia Lanjut Edisi 1, Jakarta, Pustaka Obor Populer.
Mycek, M. J, Harvey, R.A. dan Champe, P.C., (2001), Farmakologi Ulasan Bergambar 2nd ed. H. Hartanto, ed.Widya Medika : Jakarta
Pambudi, Riana. (2017). Asuhan Keperawatan Pada Ny. R Dengan Bronkhopneumonia Di Ruang Kenanga Rsud Dr. R. Goeteng Taroenadibrata Purbalingga. Diss. Universitas Muhammadiyah Purwokerto.
Polii, E., Mambo, C. D., & Posangi, J. (2018). Gambaran Evaluasi Terapi Antibiotik pada Pasien Bronkopneumonia di Instalasi Rawat Inap Anak RSUP Prof. Dr. RD Kandou Manado Periode Juli 2017–Juni 2018. eBiomedik, 6(2).
Pradipta, I. S., Febrina, E., Ridwan, M. H., & Ratnawati, R. (2012). Identifikasi pola penggunaan antibiotik sebagai upaya pengendalian resistensi antibiotik. Indonesian Journal of Clinical Pharmacy, 1(1), 16-24.
PRICE, S. A., WILSON, L. M., & ANUGERAH, P. (1995). Patofisiologi: Konsep Klinis Proses-proses Penyakit (Pathophysiology Clinical Concepts of Disease Processes), Buku I.
Said M. Pneumonia. In: Rahajo NN,Supriyatno B, Setyanto DB, editors. Buku Ajar Respirologi Anak.edisi pert. jakarta: IDAI; 2015. p. 350–64.
Siswanto. (2014). Kajian Resistensi. In: Seminar Nasional dan Diskusi Interaktif Resistensi Antimikroba. Jakarta: Badan Litbang Kesehatan: 1-3.
Tjay, Tan Hoan dan Kirana Rahardja. (2007). Obat-Obat Penting Khasiat, Penggunaan dan Efek-Efek Sampingnya, Edisi Keenam, 262, 269-271, PT. Elex Media Komputindo:Jakarta
World Health Statistics: World Health Statistics (2015). Genewa; 2015; p. 55-86.
